申请人:Axxima Pharmaceuticals Aktiengesellschaft
公开号:EP1389461A1
公开(公告)日:2004-02-18
The present invention relates to vinylpyrimidine-2-one derivatives of the general formula (I):
Furthermore the present invention relates to vinylpyrimidine-2-one derivatives and of the general formula (Ia):
wherein R1 to R6 in formula (I) and in formula (Ia) represent independently of each other a variety of different substituents comprising alkyl, aryl, aralkyl, alkylaryl, heteroaryl groups and monofunctional moieties. The compounds are used as antivirals, especially against herpes and HCMV (Human Cytomegalovirus).
本发明涉及一般式(I)的乙烯基嘧啶-2-酮衍生物,以及一般式(Ia)的乙烯基嘧啶-2-酮衍生物,其中在式(I)和式(Ia)中,R1至R6独立地表示各种不同的取代基,包括烷基,芳基,芳基烷基,烷基芳基,杂环芳基和单官能团。该化合物可用作抗病毒药物,特别是用于抗疱疹病毒和人类巨细胞病毒(HCMV)。